compared to YAMA1 and YAMA2 (7 vs 10 and 14%, p¼.002). The groups were similar in the rates of intervention for abnormal fetal surveillance (2.1 vs 2.7 and 2.7%, p¼.94). VAMA was associated with more cesarean delivery, preterm birth (42.6 vs 14.6 and 17.2%, p<.001), and very preterm birth (11.7 vs 3.5 and 3.7%, p<.001). Accordingly, VAMA was also associated with a higher rate of NICU admission and very low birthweight compared to YAMA1 and YAMA2. No difference in stillbirth rate was found between groups (0 vs 0.5 and 0.5%, p¼.72). After controlling for confounding variables, maternal age (per year) [OR 1.089; 95%CI 1.05-1.1] and comorbidity [OR 4.67; 95%CI 2.2-9.5] were associated with preterm birth but not obesity. CONCLUSION: Very advanced maternal age is associated with more preterm birth, but comorbid conditions appear to be the primary driving factor. This information may assist in directive counseling of women who desire pregnancy at advanced ages. OBJECTIVE: The Ex-Utero Intrapartum Treatment (EXIT) procedure is used to secure the airway for fetuses with prenatally diagnosed airway obstruction prior to postnatal life. Because EXIT is performed under deep maternal general anesthesia for uterine relaxation, and because of prolonged uterine distention from polyhydramnios, EXIT carries a higher risk profile than routine cesarean section. We describe here the obstetrical course, and maternal outcomes of a series of patients with fetal neck mass delivered via EXIT. STUDY DESIGN: Retrospective chart review of patients delivered between January 2001 and April 2018 in our tertiary referral fetal center. Outcome variables included gestational age (GA) at delivery, polyhydramnios, need for emergency EXIT, preterm premature rupture of membranes (PPROM), placental location, maternal estimated blood loss, transfusion requirements, and length of hospital stay. Data were tested for normality and reported as median [range] and n (%). RESULTS: A total of 21 patients delivered by EXIT were evaluated (fetal indication: lymphatic malformation, n¼10 and teratoma, n¼11). The median EGA at the time of diagnosis and delivery were 20 [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] and 36 [30] [31] [32] [33] [34] [35] [36] [37] [38] weeks, respectively. 17(81%) of the patients developed polyhydramnios at a median GA of 30 [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] weeks, of whom 10 (58.8%) underwent amnioreduction. 9 (42.9%) of the EXIT procedures were performed emergently, 5 (23.8%) being for PPROM. Maternal estimated blood loss was 1000 [500-2000] mL; 7 (33.3%) patients received a blood transfusion. The median maternal hospital stay was 4 [4-10] days. The table shows the demographics and obstetric outcomes of the study subjects. CONCLUSION: Even with full preparedness 40% of our EXIT cases were emergent, highlighting the need for an experienced and prepared multidisciplinary physician and nursing team capable of rapid deployment. Even with such a team one third of our patients required a blood transfusion during or after her EXIT procedure, highlighting the risks of this type of delivery. This information may be useful for counseling patients who are candidates for EXIT.
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